Double-blind, Placebo-controlled, Multicenter Randomized Clinical Trial to Evaluate Short-term Efficacy of Palliative Treatment With Methylphenidate in Asthenia in Advanced Cancer Patients
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Intensity of asthenia assessed with the verbal numeric scale (VNS) included on the Edmonton Symptom Assessment System (ESAS)
We are looking for a difference between goups (methylphenidate versus placebo) of 1.5 (numeric rating scale: o to 10)
After six days of therapy
No
Carlos Centeno Cortes, MD, Phd
Study Chair
Clinica Universidad de Navarra
Spain: Agencia EspaƱola de Medicamentos y Productos Sanitarios
METILAS
NCT01773837
January 2012
Name | Location |
---|